2017 ADVISORY BOARD

The Board of Reference is entirely made up of high level representatives from biotechs, academia and big pharma who are actively working within antibody discovery, development and commercialisation, and who will advise and guide the programme in 2017 – a year when the event is set to grow enormously.

Puja Sapra

Puja Sapra
Executive Director

Pfizer

Frank Walsh

Frank Walsh
Chief Executive Officer

Ossianix

Christian Klein

Christian Klein
Head Oncology Programs

Roche

Dario Neri

Dario Neri
Founder, Professor of Chemistry and Applied Bios

Philogen, Swiss Federal Institute of Technology Zurich

Janice Reichert

Janice Reichert
Executive Director

The Antibody Society

Scott Dylla

Scott Dylla
Vice President of Research & Development Chief Scientific Officer

Abbvie Stemcentrx

Mark Chiu

Mark Chiu
Associate Director, Multispecific Biologics Engineering

Jannssen

Ulf Grawunder

Ulf Grawunder
Chief Executive Officer & Founder

NBE Therapeutics

Sonia Quaratino

Sonia Quaratino
Global Clinical Program Leader

Novartis




John Lambert,

             John Lambert
EVP & Distinguished Research Fellow

Immunogen 

 

Diego Ellerman,

Diego Ellerman
Principal Scientific Researcher

Genentech

 

Michael Streit

Michael Streit ,
Senior Director, Clinical Leader Research, Translational Medicine and Early Development, Oncology,
Janssen

Marc Damelin

Marc Damelin
Associate Director

Pfizer

 



Prathima Acharya

Prathima Acharya
Consultant

 JSR Life Sciences/KBI Biopharma

 

 Seth Ettenberg

Seth Ettenberg
CSO

Unum Therapeutics

 

 

Alain Beck

Alain Beck
Head of Physico-Chemistry Department
Pierre Fabre , Associate Editor, mAbs


 

 

 André Choulika

André Choulika
CEO

Cellectis



Renier Brentjens

Renier Brentjens
Director, Cellular Therapeutics

Memorial Sloane Kettering Cancer Center

 

 

 

Alain Vertes

Alain Vertes
Managing Director

NxR Biotechnologies




Theresa Goletz

Theresa Goletz
Global Head, NBE Drug Disposition,

EMD Serono

 


David Gilham

David Gilham
Vice President of Research and Development 

Celyad

 

 

 

 

BOOK YOUR PLACE TODAY